Wells Fargo
MR

Wells Fargo’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Wells Fargo’s Portfolio MR Stock Details MR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,305,793
Closed -$35.4M – 6689
2015
Q4 		$35.4M Sell
1,305,793
-1,170,475
-47% -$30.2M 0.01% 944
2015
Q3 		$54.2M Sell
2,476,268
-309,125
-11% -$7.89M 0.02% 709
2015
Q2 		$79.4M Buy
2,785,393
+39,399
+1% +$1.15M 0.03% 603
2015
Q1 		$75.1M Buy
2,745,994
+492,333
+22% +$13.6M 0.03% 608
2014
Q4 		$59.5M Buy
2,253,661
+1,963,246
+676% +$57.5M 0.02% 672
2014
Q3 		$8.76M Buy
290,415
+267,537
+1,169% +$8.29M ﹤0.01% 1896
2014
Q2 		$720K Buy
22,878
+3,040
+15% +$96.5K ﹤0.01% 3721
2014
Q1 		$643K Buy
19,838
+18,372
+1,253% +$643K ﹤0.01% 3746
2013
Q4 		$53K Sell
1,466
-58,820
-98% -$2.29M ﹤0.01% 4733
2013
Q3 		$2.34M Buy
60,286
+2,164
+4% +$87.2K ﹤0.01% 2779
2013
Q2 		$2.18M Buy
+58,122
New +$2.29M ﹤0.01% 2762

Other funds holding MR

Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Wells Fargo's MR Position: Q1 2016 in Review

Wells Fargo sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 1,305,793 shares — an estimated $35.4M sold.

Wells Fargo first reported a position in MR in Q2 2013 and held it in 11 quarters. The position peaked at $79.4M in Q2 2015. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

  • Wells Fargo reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
  • Wells Fargo sold 1,305,793 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $35.4M.
  • Wells Fargo first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and held it in 11 quarters.
  • Wells Fargo's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $79.4M in Q2 2015.
  • 2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on Wells Fargo's 13F filing for Q1 2016, filed 16 May 2016.